Absci vs Oracle
Side-by-side comparison
| Absci | Oracle | |
|---|---|---|
| Product | Absci Drug Creation | Cerner Enviza |
| Category | Drug Discovery AI | Research Discovery |
| What it does | Unlocking new drug candidates faster by integrating AI with proprietary wet-lab data. | Delivering data-driven insights and research services for the life sciences industry. |
| Pricing model | Partnership / Per Project | — |
| Free trial | No | — |
| Target company size | Enterprise, Mid-Market | SMB, Mid-Market, Enterprise |
| Deployment | Cloud/SaaS | SaaS |
| Integrations | Laboratory Automation, Protein Expression Systems | Salesforce, SAP, Shopify, Snowflake, Workday |
| API available | Yes | Yes |
| Certifications | SOC 2 Type II, ISO 27001 | SOC 2, GDPR, HIPAA |
About Absci Drug Creation
Absci Drug Creation is an AI-powered drug discovery platform that integrates generative AI with high-throughput wet-lab data to design, predict, and optimize novel therapeutic proteins. It is used by biopharmaceutical companies and researchers to accelerate drug discovery, de-risk development, and bring better therapeutics to market faster. Its key differentiation lies in its ability to generate a
Use cases: Discovery of novel antibody therapeutics with enhanced binding and developability., Optimization of existing protein drugs for improved stability, potency, or reduced immunogenicity., Identification and validation of novel therapeutic targets for various disease areas., Accelerated lead candidate selection by predicting key properties early in the discovery funnel., De-risking drug development by assessing developability and manufacturability of candidates.
About Cerner Enviza
Cerner Enviza, a wholly-owned subsidiary of Oracle Corporation, specializes in providing data-driven insights and research services specifically tailored for the life sciences industry. It forms a crucial part of Oracle's broader healthcare offerings, leveraging Oracle's robust cloud infrastructure and technological capabilities to support advancements in medical research and patient care. The pl
Use cases: Accelerating drug discovery and development., Optimizing clinical trial design and execution., Generating real-world evidence for regulatory submissions., Identifying patient cohorts for targeted therapies., Improving post-market surveillance and pharmacovigilance.